Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:57:12.801Z.
Calculation as of: 2026-10-06T15:57:12.801Z.
Quote observation: 2026-10-06T15:54:45.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9bf447c1d5373d17b51517f64cfe8ce44e33b4ae98b3907fdc05662a19d62e0e
EARNINGS YIELD
N/A
Metagenomi, Inc. Common Stock
Market Cap
$40.00M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.92M
Earnings Yield
N/A
TTM Avg
0.70%
3Y Avg
1.26%
5Y Avg
6.45%
Market Cap
$43.56M
Earnings Yield
N/A
TTM Avg
14.15%
3Y Avg
10.66%
5Y Avg
10.66%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Metagenomi, Inc. Common Stock (MGX) | $40.00M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $39.90M | 4.32% | 2.93% | 2.58% | 2.58% |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.26M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.92M | N/A | 0.70% | 1.26% | 6.45% |
| Precipio, Inc. (PRPO)vs › | $41.92M | N/A | N/A | N/A | N/A |
| Incannex Healthcare Limited (IXHL)vs › | $38.35M | N/A | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $37.28M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $43.56M | N/A | 14.15% | 10.66% | 10.66% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.63M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.03M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
